{"disease":{"id":"endometrioid-carcinoma-ovary","name":"endometrioid carcinoma ovary"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06274541","title":"Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Cancer Trials Ireland","has_results":false},{"nct_id":"NCT05080556","title":"Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT04814875","title":"A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":16,"lead_sponsor_name":"THERAPIM PTY LTD","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}